Structural identification of degradants of moexipril by LC-MS/MS-Reference-Cited by-同舟云学术

Structural identification of degradants of moexipril by LC-MS/MS

Published:2017-06-07 Issue:11 Volume:31 Page:e4004
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Challa Purushotham Reddy¹^ORCID,K. Ramakrishna²,K. M. V. Narayana Rao¹

Affiliation:

1. Inogent Laboratories Limited; IDA, Nacharam, Hyderabad 500076 India

2. GITAM institute of Science and Technology; Visakhapatnam 530045 India

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference14 articles.

1. Development of membrance electrode for the specific determination of moexipril hydrochloride in dosage forms and biological fluids;Belal;Portugaliae Electrochimica Acta,2009

2. Vascular remodeling: The role of angiotensin converting enzyme inhibitors;Chrysant;American Heart Journal,1998

3. Application of a validated, stability indicating LC method to stress degradation studies of ramipril and moexipril;Elshanawane;Hcl. Chromatographia,2008

4. EMEA 2003 European medicines agency note for guidance on stability testing: Stability testing of existing active substances and related finished products, committee for proprietary medicinal products

5. Simultaneous determination of moexipril hydrochloride and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods;Erturk;Journal of Pharmaceutical and Biomedical Analysis,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension;International Journal of Environmental Research and Public Health;2019-03-14